Phase II pharmacodynamic trial of erlotinib in previously treated patients with advanced non-small-cell lung cancer (NSCLC): Study resultsEnriqueta Felip,Frederico Rojo,Martin Reck,Astrid Heller,Barbara Klughammer,Heiko Maacke,Joachim Mocks,Ulrich Brennscheidt,Ulrich Gatzemeier,Jose BaselgaANNALS OF ONCOLOGY(2006)引用 0|浏览18暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要